BSEM 9.80 BioStem Technologies, Inc.
| Range: | 2.26-15.5 | Vol Avg: | 34256 | Last Div: | 0 | Changes: | -0.68 |
| Beta: | 1.88 | Cap: | 0.20B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Mar 17 2015 | Empoloyees: | 2 | ||
| CUSIP: | CIK: | 0001658678 | ISIN: | US0906842002 | Country: | US | |
| CEO: | Mr. Jason V. Matuszewski | Website: | https://www.biostemtechnologies.com | ||||
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow